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Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional enzyme related with
Huntington’s, Parkinson’s and Alzheimer’s diseases. The ability of negatively charged membranes
to induce a rapid formation of GAPDH amyloid ﬁbrils has been demonstrated, but the mechanisms
by which GAPDH reaches the ﬁbrillar state remains unclear. In this report, we describe the structural
changes undergone by GAPDH at physiological pH and temperature conditions right from its inter-
action with acidic membranes until the amyloid ﬁbril is formed. According to our results, the GAP-
DH-membrane binding induces a b-structuring process along with a loss of quaternary structure in
the enzyme. In this way, experimental evidences on the initial steps of GAPDH amyloid ﬁbrils forma-
tion pathway are provided.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a well-
studied protein for its role in cellular energy production as a glyco-
lytic enzyme. However, current evidences reveal that this enzyme
is actually a multifunctional protein displaying a number of diverse
cellular functions unrelated to glycolysis [1]. These functions in-
clude transcription activation [2], metabolic switch between the
cytosol and the nucleus linking the metabolic state to the gene
transcription [3], membrane fusion [4], microtubule bundling [5],
and apoptosis through its binding to DNA as a transcription activa-
tor. GAPDH is also implicated in some neuronal diseases. In fact,
immunoﬂuorescence analysis revealed that GAPDH is co-localized
with a-synuclein in Lewy bodies on Parkinson´s disease [6] and
drugs that are currently in use for treatment bind to or affect GAP-
DH function [7]. Moreover, several studies have shown that GAPDH
is located in amyloid plaques [8,9] and binds the amyloid precursor
protein [10] and Ab peptide [11], indicating that GAPDHmight play
a role in the progression of Alzheimer´s disease. In vitro, oxidants
can induce amyloid-like aggregation of GAPDH via the formation
of intermolecular disulﬁde bonds [12]. At physiological conditionschemical Societies. Published by E
buco 461 (4000), Tucumán,
ín).of pH and temperature, GAPDH is capable to undergo strong con-
formational changes from globular soluble to b-sheet enriched
amyloid structure when they interact with membranes containing
anionic phospholipids [13]. The ﬁbrils formed under this condi-
tions appear to be analogous to those isolated in vivo [13], and
hence this system constitutes a good model to study the molecular
basis of amyloid ﬁbril formation in vitro.
In the present work, kinetics and structural analysis were per-
formed in order to detect the changes undergone by the enzyme
upon its binding to negatively charged membranes. Our experi-
mental evidences allow us to suggest that a b-structuring and tet-
ramer dissociation processes occurs prior to the appearance of
protein aggregates. The results presented herein offers novel in-
sight into the initial steps of the amyloid ﬁbrils formation pathway.2. Materials and methods
2.1. Materials
Glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12) and
Thioﬂavin T (ThT) were purchased from Sigma–Aldrich (St. Louis,
MO). Dioleylphosphatidylcholine (DOPC) and dioleylphosphatidic
acid (DOPA) were obtained from Avanti Polar lipids and their pur-
ity controlled by TLC.lsevier B.V. All rights reserved.
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Small unilamellar vesicles (SUV) were prepared according to Fi-
ner [14]. Brieﬂy, appropriate amounts of DOPC and DOPA were dis-
solved in chloroform/methanol (2:1, vol/vol) and dried under
nitrogen. The lipids were rehydrated in the appropriate buffer
and sonicated on ice under nitrogen with a probe-type soniﬁer. Cy-
cles of sonication (1 min) and cooling (1 min) were repeated up to
15 times until the initially cloudy lipid dispersion became translu-
cent. The suspension was centrifuged for 15 min at 1100g to ob-
tain a pure SUV suspension.
2.3. GAPDH enzymatic activity assay
GAPDH enzymatic activity was measured following the in-
crease in the absorbance at 340 nm of NADH using a Beckman
DU-7500 spectrophotometer. Brieﬂy, 0.16 mg/ml of GAPDH in
the presence or in the absence of 0.5 mM DOPC:DOPA (9:1) lipo-
somes were incubated at 37 C, pH 7.4. Afterwards, the enzymatic
reaction was carried out at 25 C and was initiated by the addi-
tion of a 20 ll aliquot of the previous suspension to a reaction
mixture containing 100 mM glycine, 100 mM Na2HPO4, 5 mM
EDTA, 1.5 mM NAD and 2 mM glyceraldehyde-3-phosphate at
pH 9.0.
2.4. Hydrogen–deuterium exchange measurement
The lyophilized protein was dissolved in 50 ll of deuterated
buffer alone or containing 12.5 mM of DOPC:DOPA liposomes
and immediately mounted into an IR cell with a path length of
100 lm. The infrared spectra were recorded every minute up to
180 min. Sixteen scans were collected for each time interval. To
compare the spectra in H2O and D2O, they were normalized using
the amide I band in H2O to the amide I band in D2O at 1 min as ref-
erence. The spectrum collected after exchange for 24 h was used as
the fully deuterated spectrum.
2.5. Amide proton exchange rate
The H–D exchange of GAPDH was followed by FT-IR measuring
the apparent intensity changes of the amide II band, located
around 1548 cm1 [15]. The fraction of unexchanged amide proton,
F, was calculated at various time intervals as follows:
F ¼ ðAI  AII1Þ=AIx
where AI and AII are the maximum absorbance of the amide I and II
bands, respectively, AII1 is the amide II maximum absorbance of
fully deuterated protein, and x is the ratio of AIIo/AIo, with AIIo
and AIo being the maximum absorbance for the amide II and amide
I bands, respectively, of GAPDH in H2O [16].
2.6. Thioﬂavin T ﬂuorescence measurements
Eighty microliters of a GAPDH (4 mg/ml) solution were mixed
with 2 ml of 20 mM HEPES, pH 7.4, containing 25 lM ThT and
incubated at 37 C in the presence or in the absence of
0.5 mM of DOPC or DOPC:DOPA (9:1, 8:2 or 7:3 molar ratios)
liposomes in a quartz cuvette. The scattering, measured in the
absence of ThT, was subtracted. All ﬂuorescence measurements
were carried out with an ISS (Champaign, IL, USA) PC1 spectro-
ﬂuorometer according to Levine et al. [17]. The excitation wave-
length was set at 450 nm with emission measured at 482 nm
using a slit width of 0.5 and 1 nm for excitation and emission
light paths respectively. Each experiment was conducted in
triplicate.2.7. Fourier transform infrared spectroscopy measurements
GAPDH solutions for infrared studies were prepared in 20 mM
HEPES, pD 7.4. Around 50 ll of sample containing 4 mg/ml of GAP-
DH were assembled in a thermostated cell between two CaF2 win-
dows with 100 lm spacers in a demountable liquid cell (Harrick
Scientiﬁc, Ossining, NY). The samples were recorded in a Nicolet
5700 spectrometer equipped with a DTGS detector (Thermo Nico-
let, Madison, WI). The sample chamber was permanently purged
with dry air. Solvent subtraction, deconvolution, determination of
band position and curve ﬁtting of the original amide I band were
performed as previously described [18]. Protein structural analy-
ses, either in the absence or in the presence of the liposomes were
repeated three times with fresh new samples to test the reproduc-
ibility of the measurements. In all cases, the differences among the
three experiments were lower than 3%. The error in estimation of
the percentage of secondary structure depends mainly on the re-
moval of spectral noise, and it was estimated to be 2% [19].
2.8. Transmission electron microscopy
GAPDH (4 mg/ml) solution in 20 mM HEPES, pH 7.4, were
mixed with 12.5 mM of DOPC and DOPC:DOPA (9:1) during
120 min. The samples were primary ﬁxed in Karnovsky ﬁxative
buffer. After 3 h at 4 C, pellets were embedded in agar-agar and
transferred to 1% osmium tetroxide overnight. After rinsed in dis-
tilled water, the sample was treated with an aqueous solution of
2% uranyl acetate for 40 min. After ﬁxation, samples were gradu-
ally dehydrated in alcohols of increasing strength, followed by ace-
tone. The inﬁltration with the embedding medium was performed
in Spurr resin (Pelco Int., CA, USA). Ultrathin sections mounted on
copper grids were stained with uranyl acetate and examined with
a Zeiss EM 109 transmission electron microscope.
3. Results
3.1. Lipid-induced conformational changes in GAPDH
The glycolytic activity of GAPDH in the presence of acidic mem-
branes shows an exponential decay over time (Fig. 1A). On the con-
trary the enzyme preserves its activity while incubated in the
absence of liposomes.
In order to test for structural rearrangements on GAPDH induced
by acidic liposomes, the H–D exchange rate was followed by infra-
red spectroscopy. The kinetics of the process in the absence or pres-
ence of DOPC:DOPA (9:1) liposomes was ﬁtted to a two-
exponential decay model (Fig. 1B) which was satisfactorily used
in other systems [20,21] . Because of the complexity of the overall
H–D exchange process in proteins, only qualitative analyses were
performed. The amount of amide protons exchanged in the pres-
ence of acidic liposomes is signiﬁcantly higher and the overall pro-
cess faster than in its absence. These data suggest that
conformational changes occur with the exposition of new protein
solvent accessible surfaces. The main changes in the H–D exchange
takes place within the ﬁrst 5 min of protein–membrane interaction.
3.2. Kinetics of lipid-induced GAPDH amyloid ﬁbrils formation
The ability of GAPDH to form amyloid ﬁbrils in the presence of
acidic membranes was investigated through monitoring maximal
ThT emission intensity over 80 min of incubation at 37 C and
shown in Fig. 2A. In the presence of DOPC:DOPA (9:1) membranes,
the aggregation kinetics shows a lag phase (10 min) followed by an
exponential phase which corresponds to the amyloid ﬁbril elonga-
tion. The amount of negative charge in the bilayer increases the ex-
Fig. 1. Glycolytic activity (A) and amide I proton exchange rates in D2O (B) for GAPDH in the absence (ﬁlled circles) or in the presence (empty circles) of DOPC:DOPA (9:1)
liposomes at 37 C, pH 7.4. The lines represent best ﬁts to the data points.
Fig. 2. (A) Kinetics of lipid-induced GAPDH amyloid ﬁbrils formation. The ThT
ﬂuorescence emission of a 0.16 mg/ml GAPDH solution in the absence (ﬁlled circles)
or in the presence of 0.5 mM DOPC (empty circle). 9:1 (inverted triangle), 8:2
(square), 7:3 (triangle) DOPC:DOPA liposome’s suspension registered as a function
of time. (B) Lipid-induced GAPDH ﬁbrils observed by transmission electronic
microscopy. GAPDH solution (4 mg/ml) was incubated at 80 min 37 C of incuba-
tion in the presence of 12.5 mM DOPC:DOPA (9:1) suspension. The scale bars at the
bottom correspond to 100 nm.
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phase. Fig. 2B shows the ﬁbrilar nature of the aggregates as well
as large unilamellar liposomes formed as a consequence of the fus-
ogenic activity previously described for GAPDH [4].
In the absence of liposomes, as well as in the presence of zwit-
terionic membranes, the protein kept its soluble state and no con-
siderable amount of amyloid ﬁbrils was detected.3.3. Characterization of the GAPDH structural changes induced by
acidic membranes
In order to characterize the structural rearrangement under-
gone by GAPDH in the presence of acidic membrane, infrared spec-
troscopy analyses were performed (Fig. 3 and Table 1) using
DOPC:DOPA (9:1) membranes since a 10 min lag phase allows
structural changes measurements before the ﬁbrillation process
begins. After 80 min of incubation at 37 C, GAPDH remained stable
and no changes in amide I spectra were observed (Fig. 3A). The
dominant band at 1654 cm1 reﬂects the content of a-helical while
the band component at 1638 cm1 indicates the presence of b-
sheet with some contributions from non-structured conformations
[22]. The band located around 1667 cm1 arises from b turns
[23,24]. The band at 1681 cm1 may also arise from a small contri-
bution of the high-frequency vibration of the antiparallel b-strand
[23]. Bands appearing at about 1642 cm1 are assigned to non-
structured conformation [22]. The band at 1623 cm1 corresponds
to interoligomeric contact as will be described in the following sec-
tion. According to the band assignment given above, the GAPDH
structure consists of 30% a-helix, 29% b-sheet, and 11% b-turns
(Fig. 3B and Table 1). This secondary-structure content is in good
agreement with those obtained by X-ray analysis [25].
After 80 min of incubation at 37 C in the presence of DOPC:DO-
PA liposomes, signiﬁcant structural changes on the protein were
evidenced along with the emergence of a new band corresponding
to protein aggregation at 1616 cm1 [18]. In this way, it is notable
the increase of the b-sheets, b-turns and aggregation bands, while
b-helix and interoligomeric bands diminished (Fig. 3C and Table 1).
In addition, the contribution from random coil becomes almost
undetectable. In accordance with the observations derived from
ﬂuorescence assays, upon incubation with DOPC liposomes the
protein kept its soluble state and no considerable amount of amy-
loid ﬁbrils was detected (data not shown).
3.4. Identiﬁcation of GAPDH interoligomeric contact band
Bands in the 1630–1600 cm1 region are not common in native
proteins. The band at 1623 cm1 has been assigned to protein–pro-
tein contacts in native oligomeric proteins as well as b-strands not
forming b-sheets [18,26]. Considering that GAPDH can be dissoci-
ated into dimmers or monomers at 45 C [27], the thermal tetra-
mer dissociation was studied by infrared spectroscopy in order to
achieve an unmistakable assignment of the 1623 cm1 band.
Fig. 4 shows that this band diminishes with increasing temperature
until it vanishes at 50 C, which strongly suggests that it arises
Table 1
Band position (cm1) and percentage area (%) corresponding to the components
obtained after curve ﬁtting of the GAPDH amide I band after 80 min of incubation at
37 C in the absence and in the presence of DOPC:DOPA liposomes.
GAPDH +DOPC:DOPA
Position (cm1) Area (%) Position (cm1) Area (%)
1681 8 1682 5
1667 12 1667 18
1654 29 1653 22
1642 18 1643 <1
1638 21 1637 45
1623 12 1623 3
1616 – 1616 7
Fig. 4. Relative areas of 1623 cm1 (open triangles) and 1616 cm1 (ﬁlled triangles)
bands obtained after curve ﬁtting of GAPDH amide I band. The protein spectra were
registered as a function of temperature. The contribution of each band to the amide
I was performed according to experimental procedures.
Fig. 3. (A) FT-IR absorption spectra in the amide I region GAPDH before (solid line)
and after 80 min of incubation at 37 C in the absence (dotted line) and in the
presence (dashed lines) of 12.5 mM DOPC:DOPA (9:1) liposomes. Reconstruction of
the amide I band from the components at 37 C before (B) and after 80 min of
protein–membrane interaction (C).
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tant to note that the GAPDH intermolecular hydrogen bonds from
protein aggregation, characterized by the 1616 cm1 band, be-
comes evident at about 45 C, just when the tetramer is being
dissociated.
3.5. Time-progression of GAPDH structural changes
A detailed time-progression of the structural changes occurred
during the lipid-induced GAPDH refolding are depicted in Fig. 5.The protein secondary structure changes derived from the infrared
spectrum are shown in Fig. 5A. The main structural changes were
observed during the lag phase, i.e. within the ﬁrst 10 min of incu-
bation, where the signal from b-sheet strongly increases at the ex-
pense of the unordered structure. On the contrary, the a-helix
content shows a slower decrement and this process covers the
lag and the amyloid ﬁbrils growth phase. Fig. 5B shows the band
areas related with interchain interaction and it seems clear that
subsequent to the protein-membrane binding, the tetramer began
its dissociation and the intermolecular aggregation started. It is
important to take into account that in the lag phase, both, the main
b-structuring and the tetramer dissociation have been almost com-
pleted (Fig. 5A and B).
4. Discussion
Independent analyses demonstrate that GAPDH might be in-
volved in the pathogenesis of some protein misfolding diseases
[28], but its precise role in neurodegenerative diseases is still un-
known. The observation that the interaction of soluble Ab peptide
and denatured forms of GAPDH is rather speciﬁc and not due to its
adsorption to other denatured proteins lead to the hypothesis that
non-native forms of GAPDH might act as a seed in the formation of
amyloid structures during Alzheimer’s disease [29]. Acidic mem-
branes can also trigger the formation of GAPDH amyloid ﬁbrils at
physiological conditions, and the formed ﬁbrils are analogous to
those found in some pathological conditions [13]. In this way,
the study of the physicochemical basis of the ability of this enzyme
to form amyloid ﬁbrils acquired relevance. In the present work, the
ﬁrst description of the kinetics and conformational events under-
went by GAPDH right from its binding to acidic membrane until
the cross-b structure becomes evident is reported. The kinetic of
the lipid-induced GAPDH ﬁbrillation showed that after a short
lag phase of about ten minutes, the amyloid ﬁbrils growth phase
proceeded in an exponential way. This result is consistent with a
nucleation-dependent process that appears to be a common fea-
ture in some amyloid ﬁbril formation [30]. The main conforma-
tional changes in the protein occurs within the lag phase, where
a protein b-structuring was evidenced by infrared techniques.
The GAPDH–DOPC:DOPA binding energy, which is about
5.09 kcal/mol [31], could be used to support the observed confor-
mational change resembling the SNARE´s systems [32].
In this paper, it is also demonstrated that in GAPDH, the
1623 cm1 band from the infrared spectrum could be unambigu-
ously assigned to interoligomeric interaction and allows to
monitoring the tetramer dissociation. According to our results,
Fig. 5. Relative contribution of secondary structure (A) and interchain interaction (B) to the amide I band as a function of time. The infrared spectra were recorded after a
GAPDH solution (4 mg/ml) was added to a 12.5 mM DOPC:DOPA liposome suspension. Area percentages at each time are represented for b-sheets (ﬁlled circles), a-helix
(open circles), b-turns (ﬁlled triangles), random coil (open triangles), interoligomeric contact (open square) and protein aggregation (ﬁlled square).
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could explain the increment on the protein’s solvent accessible
area, as evidenced by the H–D exchange, which might arise from
lost of the interoligomeric contacts (Fig. 1B).
According to GAPDH X-ray crystallography the interface be-
tween two monomer has an edge to edge b-sheet structure, while
the dimmers pack together through loops and random coil struc-
tures [25]. Thus, when GAPDH interacts with acidic membranes,
the random coil (including those belonging to the dimmer inter-
face) could be organized into b-structures leading to the tetramer
dissociation and the concomitant exposition of hydrophobic sur-
faces triggering the interchain aggregation. Moreover, the tetramer
dissociation could also explain the loss of glycolytic activity ob-
served in the presence of acidic membranes (Fig. 1A) since this
enzymatic activity is restricted to the tetramer [33].
The ﬁrst critical step in protein ﬁbrillogenesis is the partial
unfolding of the protein [34]. However, it is difﬁcult to trap and
characterize such partially folded species under physiological con-
ditions because they are only transiently populated on the ﬁbrilla-
tion pathway [35]. It has been assumed that conformational
change from a-helix into b-sheet may be a key step in the forma-
tion of amyloid ﬁbrils in some proteins [35]. However, according to
our results, in GAPDH, the b-sheet increment is ﬁrst at the expense
of random coil while the a-helix unfolding seems to be a less
important process.
The loss of quaternary structure and the partial interconversion
of secondary structure elements detected in the lag period, allow
us to characterize intermediate species in the GAPDH folding path-
way. The isolation of these intermediate species is difﬁcult due to
the short duration of the lag period. This fact alongside the high light
scattering produced by the presence of lipid vesicles prevents the
study of these intermediates by other classical biophysical tech-
niques. In this scenario, infrared spectroscopybecomes a useful tool.
The data presented herein provide some insights on the GAPDH
misfolding pathway since intermediates folding species were
experimentally detected. This could shed light on the molecular
mechanisms that drive the GAPDH amyloid formation, associated
with various, often highly debilitating, diseases like Alzheimer’s,
Parkinson’s or Huntington’s disease, for which no sufﬁcient cure
is available yet.
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